ArticleSmall methods2026
Breaking the Low Concentration Barrier of Single-Molecule Fluorescence Quantification to the Sub-Picomolar Range.
Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A General Analytic Approach for Rapid Diagnostics by a Simple Algorithm for Fluorescence Single Molecule Counting.Biosensors · 2026Article
- Coincident Fluorescence-Burst Analysis of Actin Cargo Molecules in Secreted Single Diffusing Extracellular Vesicles From Human Induced Pluripotent Stem Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Breaking the Low Concentration Barrier of Single-Molecule Fluorescence Quantification to the Sub-Picomolar Range.Small methods · 2026Article
- High-Throughput Fabrication of Zero-Mode Waveguide Nanoaperture Arrays with Sol-Gel Nanoimprint Lithography for Enhanced Single Molecule Fluorescence Detection.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Mie Voids for Single-Molecule Fluorescence Enhancement in Wavelength-Scale Detection Volumes.Sensors (Basel, Switzerland) · 2025Article
- Inverse Design of Multi-Wavelength Achromatic Metalens Integrated On-Chip with Planar Waveguide.Nanomaterials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Single-molecule fluorescence techniques provide exceptional sensitivity to probe biomolecular interactions. However, their application to accurately quantify analytes at the picomolar concentrations relevant for biosensing remains challenged by a severe degradation in the signal-to-background ratio. This so-called "low concentration barrier" is a major factor hindering the broad application of single-molecule fluorescence to biosensing. Here, the low concentration limit is broken into while keeping intact the confocal microscope architecture and without requiring complex microfluidics or preconcentration stages. Using fluorescence lifetime correlation spectroscopy (FLCS) and adding a diaphragm to the laser excitation beam, a limit of quantitation (LOQ) down to 0.1 pM is achieved, significantly below the state-of-the-art. The physical parameters setting the LOQ and introduce a broadly applicable figure of merit (FoM) is identified that determines the LOQ and allows for a clear comparison between experimental configurations. The approach preserves the ability to monitor dynamic interactions, and diffusion times, and distinguish species in complex mixtures. This feature is illustrated by measuring the biotin-streptavidin association rate constant which is highly challenging to assess quantitatively due to the strong affinity of the biotin-streptavidin interaction. These findings push the boundaries of single-molecule fluorescence detection for biosensing applications at sub-picomolar concentrations with high accuracy and simplified systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.